Skip to main content
Clinical Trials/ISRCTN56702353
ISRCTN56702353
Completed
N/A

A randomised controlled trial to assess the feasibility, acceptability and effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care

niversity of Cambridge (UK)0 sites600 target enrollmentMarch 2, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mental and Behavioural Disorders
Sponsor
niversity of Cambridge (UK)
Enrollment
600
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
March 2, 2009
End Date
January 31, 2011
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Cambridge (UK)

Eligibility Criteria

Inclusion Criteria

  • Patients can be included in the study if they meet all of the criteria below:
  • 1\. Current smoker (has smoked in the 7 days prior to randomisation date)
  • 2\. Able to read English and can provide written informed consent
  • 3\. Is seriously considering quitting smoking and is willing to set a quit date within the 14 days after randomisation
  • 4\. Aged 18 \- 75 years, either sex
  • 5\. Has a mobile phone and is familiar with sending and receiving SMS text messages
  • 6\. Is willing to participate in study and follow study procedures
  • 7\. Is not currently enrolled in another formal smoking cessation study or program
  • 8\. Is not using nicotene replacement therapy (NRT), bupropion (Zyban®) and varenicline (Champix®) or other pharmacotherapy at randomisation date

Exclusion Criteria

  • 1\. Do not meet all of the inclusion criteria
  • 2\. Considered by their GP to be unsuitable for the project for any reason e.g. people with severe mental impairment or severely or terminally ill
  • Co\-morbidities, for example chronic obstructive pulmonary disease (COPD), diabetes, are not excluded from the study (unless their GP considers them unsuitable). In addition, we would not exclude entry to the trial of more than one participant per household, however, should this occur, they would be assigned to the same treatment group (to minimise the potential for contamination).

Outcomes

Primary Outcomes

Not specified

Similar Trials